TWST

MKT CAP:$4B

Twist Bioscience Corp

Market Cap

$4B

Healthcare·Diagnostics & Research·🇺🇸 United States·NASDAQ

Healthcare·Diagnostics·🇺🇸·NASDAQ

Stock Price

$70.04+$37.65 (+116.24%)

Jun 8, 2026

52W High $73.9352W Low $24.16

Company Details

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data s...

CEO

—

IPO Date

Oct 31, 2018

Website

www.twistbioscience.com

Key Metrics TTM

Revenue

$409M

+17.8% YoY

Net Income

-$81M

EPS (Diluted)

Free Cash Flow

-$95M

Revenue / Share

$6.64

Gross Margin

52.1%

Operating Margin

-33.9%

Net Margin

-19.8%

FCF Margin

-23.2%

P/S

10.3x

P/E

Earnings Reports

Q3 2026

Aug 3, 2026

PENDING

Q2 2026

May 4, 2026

$111M+19.3%

Q1 2026

Feb 2, 2026

$104M+16.9%

FY 2025

Nov 17, 2025

$377M+20.3%

Q4 2025

Nov 17, 2025

$99M+16.9%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee